|Characterising dark net marketplace purchasers in a sample of regular psychostimulant users|
J Van Buskirk, A Roxburgh, R Bruno, S Naicker, S Lenton, R Sutherland, ...
International Journal of Drug Policy 35, 32-37, 2016
|New psychoactive substance use among regular psychostimulant users in Australia, 2010–2015|
R Sutherland, A Peacock, E Whittaker, A Roxburgh, S Lenton, A Matthews, ...
Drug and alcohol dependence 161, 110-118, 2016
|A systematic review of methamphetamine precursor regulations|
R McKetin, R Sutherland, DA Bright, MM Norberg
Addiction 106 (11), 1911-1924, 2011
|Motivations for new psychoactive substance use among regular psychostimulant users in Australia|
R Sutherland, R Bruno, A Peacock, S Lenton, A Matthews, C Salom, ...
International Journal of Drug Policy 43, 23-32, 2017
|Motivations, substance use and other correlates amongst property and violent offenders who regularly inject drugs|
R Sutherland, N Sindicich, E Barrett, E Whittaker, A Peacock, S Hickey, ...
Addictive behaviors 45, 207-213, 2015
|Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia|
R McKetin, AJ Dunlop, RM Holland, RA Sutherland, AL Baker, ...
Drug and alcohol review 32 (1), 80-87, 2013
|Key findings from the National Illicit Drug Reporting System (IDRS) interviews|
A Peacock, D Gibbs, R Sutherland, J Uporova, A Karlsson, R Bruno, ...
Sydney: National Drug and Alcohol Research Centre, UNSW, 2018
|Examining the opinions of people who use drugs towards drug policy in Australia|
K Lancaster, R Sutherland, A Ritter
Drugs: education, prevention and policy 21 (2), 93-101, 2014
|I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances|
A Matthews, R Sutherland, A Peacock, J Van Buskirk, E Whittaker, ...
International Journal of Drug Policy 40, 44-49, 2017
|Tobacco and e-cigarette use amongst illicit drug users in Australia|
R Sutherland, N Sindicich, G Entwistle, E Whittaker, A Peacock, ...
Drug and alcohol dependence 159, 35-41, 2016
|Australian Drug Trends 2018: Key findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews|
A Peacock, D Gibbs, A Karlsson, J Uporova, R Sutherland, R Bruno, ...
Sydney, National Drug and Alcohol Research Centre, UNSW Australia, 2018
|NSW trends in ecstasy and related drug markets 2017: findings from the Ecstasy and Related Drugs Reporting System (EDRS)|
C O’Donnell, J Uporova
National Drug and Alcohol Research Centre, UNSW Sydney, 2017
|Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in Australia|
K Butler, C Day, R Sutherland, J van Buskirk, C Breen, L Burns, S Larney
International Journal of Drug Policy 47, 102-106, 2017
|Methamphetamine Treatment Evaluation Study (MATES): Three Year Outcomes from the Sydney Site|
R McKetin, R Sutherland, J Ross, J Najman, A Baker, R Mattick, ...
National Drug and Alcohol Research Centre, 2010
|“Just doing a favor for a friend”: The social supply of ecstasy through friendship networks|
DA Bright, R Sutherland
Journal of Drug Issues 47 (3), 492-504, 2017
|New psychoactive substances: Purchasing and supply patterns in Australia|
R Sutherland, R Bruno, A Peacock, P Dietze, C Breen, L Burns, MJ Barratt
Human Psychopharmacology: Clinical and Experimental 32 (3), e2577, 2017
|Adulterants and altruism: a qualitative investigation of “drug checkers” in North America|
JJ Palamar, P Acosta, R Sutherland, MG Shedlin, MJ Barratt
International Journal of Drug Policy 74, 160-169, 2019
|Typology of new psychoactive substance use among the general Australian population|
R Sutherland, A Peacock, A Roxburgh, MJ Barratt, L Burns, R Bruno
Drug and alcohol dependence 188, 126-134, 2018
|Co‐ingestion of energy drinks with alcohol and other substances among a sample of people who regularly use ecstasy|
A Peacock, N Sindicich, M Dunn, E Whittaker, R Sutherland, G Entwistle, ...
Drug and alcohol review 35 (3), 352-358, 2016
|Criminal activity among regular ecstasy users in Australia: Prevalence and predictors|
R Sutherland, L Burns
EDRS Drug Trends Bulletin, 2012